83
Dendritic cells_Cancer
Oxford University
Cell therapy
Oncology
Hit To Lead or Lead Optimization
Researchers at the University of Oxford have identified key mutations that increase the affinity of Insulin-like Growth Factor 2 Receptor (IGFR2) for its ligand, reducing hypoglycaemia and tumour volume.
PCT-GB2017-050201